Recent research shows targeted removal of dysfunctional B cells in aged mice improves immune function and healthspan, suggesting new therapeutic avenues for combating age-related decline. A new study ...
Emerging research links aging oral microbiome with senescent cells to amplify systemic inflammation, driving diseases like Alzheimer’s and offering new intervention targets such as probiotics an...
Recent studies show targeted epigenetic reprogramming with Yamanaka factors rejuvenates neurons, reversing cognitive decline in aged mice and reducing Alzheimer’s markers, with AI enhancing safe...
DeepRare, a multi-agent AI system, achieves 10% higher accuracy than expert physicians in diagnosing rare diseases, potentially reducing diagnostic delays and transforming clinical practice with trans...
Partial OSK reprogramming rejuvenates engram neurons in aged mice, improving memory by over 50%, with recent studies enhancing safety and biotech firms advancing towards human trials. New research sho...
A new AI system, DeepRare, demonstrates superior accuracy in diagnosing rare diseases using real-time data and self-reflective reasoning, as detailed in a 2026 Nature study, with potential to reduce d...
Advanced coronary CT scans with machine learning now quantify plaque volume more accurately than LDL levels, enabling early intervention and personalized prevention for cardiovascular disease. New AI-...
Recent studies reveal elevated IL-6 levels strongly correlate with Alzheimer’s and mild cognitive impairment, highlighting inflammaging’s role and potential for lifestyle and drug interven...
Analytical post exploring CAR-T cell therapy’s potential to treat Alzheimer’s by targeting amyloid plaques, with insights from recent clinical trials and cost-benefit considerations. Innov...
New research identifies IRF7 as a critical driver of unstable atherosclerotic plaques, offering a potential therapeutic target to reduce cardiovascular events through innovative clinical trials and te...
